FITTING AN INHIBITOR INTO THE ACTIVE-SITE OF THERMOLYSIN - A MOLECULAR-DYNAMICS CASE-STUDY

Citation
Zr. Wasserman et Cn. Hodge, FITTING AN INHIBITOR INTO THE ACTIVE-SITE OF THERMOLYSIN - A MOLECULAR-DYNAMICS CASE-STUDY, Proteins, 24(2), 1996, pp. 227-237
Citations number
34
Categorie Soggetti
Biology
Journal title
ISSN journal
08873585
Volume
24
Issue
2
Year of publication
1996
Pages
227 - 237
Database
ISI
SICI code
0887-3585(1996)24:2<227:FAIITA>2.0.ZU;2-7
Abstract
We used molecular dynamics computer simulation to ''fly'' a small flex ible ligand, L-leucine hydroxamic acid, into the active site of thermo lysin. The potential, which imposed no constraints between protein and ligand, produced conformations close to the crystallographically dete rmined one. The calculations made use of the combined molecular mechan ics/grid method of Luty et al. (J. Comp. Chem. 16:454-464, 1995), in w hich atoms of the active site are free to move whereas the rest of the protein, assumed to be rigid, is represented as points of a grid, and which also includes an implicit solvation model, The method is suffic iently fast that large sets of simulations could be carried out, enabl ing statistical sampling and exploration of the effect of initial posi tion and conformation of the ligand on the probability of successful d ocking. In a charged catalytic Glu/uncharged ligand regime, when the i nitial position of the ligand was determined by random translations ar id rotations that kept the center of mass within 8.0 Angstrom Of the c rystal one, none of the 20 runs placed the ligand correctly, In a seco nd set with uncharged Glu and zwitterionic ligand, 3 of 24 similarly p laced random structures flew the ligand in sucessfully. In a third set with the same protonation scheme as the second the starting positions had randomly determined conformations but kept the hydroxamate oxygen s within 4.0 Angstrom of the zinc; in this case 22 of 25 runs reorient ed correctly, A diverse set of energetic, structural, and dynamic crit eria was used for evaluation of the calculations. The results indicate the method to be a promising tool for the rational drug design proces s. (C) 1996 Wiley-Liss, Inc.